1. Short title This Act may be cited as the Congenital Heart Futures Reauthorization Act of 2017 . 2. National congenital heart disease surveillance system Section 399V–2 of the Public Health Service Act ( 42 U.S.C. 280g–13 ) is amended to read as follows: 399V–2. National congenital heart disease research, surveillance, and awareness (a) In general The Secretary shall— (1) enhance and expand research and surveillance infrastructure to study and track the epidemiology of congenital heart disease (in this section referred to as CHD ); (2) plan and implement a public outreach and education campaign regarding CHD across the lifespan; and (3) award grants to eligible entities to undertake the activities described in subsections (b) and (c). (b) National congenital heart disease study (1) In general The Director of the Centers for Disease Control and Prevention shall plan, develop, implement, and submit one or more reports to the Congress on a study to improve understanding of the epidemiology of CHD across the lifespan, from birth to adulthood, with particular interest in the following: (A) Health care utilization of those affected by CHD. (B) Demographic factors associated with CHD, such as age, race, ethnicity, gender, and family history of individuals who are diagnosed with the disease. (C) Outcome measures, such that analysis of the outcome measures will allow derivation of evidence-based best practices and guidelines for CHD patients. (2) Permissible considerations The study under this subsection may— (A) gather data on the health outcomes of a diverse population of those affected by CHD; (B) consider health disparities among those affected by CHD, which may include the consideration of prenatal exposures